SARMs have been investigated in human studies for the treatment of osteoporosis, cachexia (wasting syndrome), benign prostatic hyperplasia, stress urinary incontinence, and breast cancer. As of 2023, there are no SARMs which have been approved by the United States Food and Drug Administration or the European Medicines Agency. Although adverse effects in clinical studies have been infrequent and mild, SARMs can cause elevated liver enzymes, reduction of HDL cholesterol levels, and hypothalamic–pituitary–gonadal axis (HPG axis) suppression, among other side effects.
**Disclaimer:** *Not for human consumption and is strictly intended for research purposes only. It is imperative that users adhere to all applicable laws and regulations when using this product. Always consult with a healthcare professional before use, especially if you have any underlying medical conditions or are taking medications. Keep out of the reach of children and use it responsibly and in full compliance with the law.*